QUALITY STATEMENT

Bone Solutions is committed to provide quality medical devices to the global medical device market-place that improve patient care, meet regulatory and customer requirements, while assuring the continual effectiveness and improvement of Bone Solutions’ Quality System.

News

  • 03/07/2018 to 03/09/2018 - AAOS - American Academy of Orthopedic Surgeons Bone Solutions, Inc. will be attending the AAOS - American Academy of Orthopedic Surgeons (AAOS) Annual Meeting March 7-9, 2018, in New Orleans, LA. Please look for us at Booth 1714.
  • 01/23/2018 - Bone Solutions Inc. Reaches 50 Implants Of Its Proprietary Magnesium-Based Bone Void Filler
  • 09/28/2017 - Bone Solutions Inc. announces 1st implantation of OsteoCrete® Magnesium-based bone void filler.
  • 09/19/2017 - Bone Solutions Inc. Launches OsteoCrete® Magnesium-based bone void filler
  • 03/04/2014 - Drew Diaz named President of Bone Solutions Inc. (BSI)
  • 06/22/2009 - Bone Solutions Inc.: Recipient of the North American Bone Graft Technology Leadership of the Year Award
  • 06/08/2009 - Bone Solutions Inc. (BSI) receives FDA 510(K) clearance for OsteoCrete®, a Magnesium-based bone void filler

ABOUT US

Bone Solutions Inc. is a Texas-based, medical device company with a vision to provide new technologies to orthopedic surgeons with a means to improve clinical outcomes. Our company is dedicated to the design, development, manufacturing and marketing of innovative Magnesium-oxide based technologies to obtain increased success rates in a multitude of orthopedic applications.

BOARD OF DIRECTORS

  • Wade Hampton - Chairman / Board Member
  • Anthony Copp - Vice Chairman and Co-Founder / Board Member
  • Tom Lally - Co-Founder / Board Member
  • Drew Diaz - President and CEO / Board Member
  • Phil Holcomb - Board Member
  • Kevin Morano - Board Member

Leadership

Drew M. Diaz – CEO

  • Over 30 years of experience working in leadership positions in healthcare and the medical device arena
  • Cofounded a US based medical device company
  • Held senior roles in medical device companies domestically and internationally
  • Has lived and worked in four different countries during his life and career
  • Managed offices in Brazil, Germany, India, China, and the United States

Brandon Roller MD, PhD – CTO

  • Medical Doctorate -University of Missouri-Columbia
  • Resident - Wake Forest Baptist Medical Center
  • Arthrex® Product Development (former)

Frankie L Morris – DIRECTOR OF ENGINEERING AND OPERATIONS

  • Over fifteen years in product development & ten years engineering project management.
  • Ten medical device patents & four pending in the United States (USPTO)
  • Over 15 medical devices in the market today which include ten different FDA 510K medical device clearances.
  • Studied Engineering at University of Toledo, Indiana State University and Technical Management at American University.

Clinical Advisors

BRANDON ROLLER, MD, PHD

  • Medical Doctorate -University of Missouri-Columbia
  • Resident - Wake Forest Baptist Medical Center
  • Arthrex® Product Development (former)

FRANCIS HORNICEK, MD, PHD

  • Professor and Chair, Department of Orthopedic Surgery UCLA Medical Center, Santa Monica
  • Former Chief of the Orthopedic Oncology Service at Massachusetts General Hospital (MGH)
  • Professor of Orthopedic Surgery at Harvard Medical School
  • Director MGH Stephan L. Harris Chordoma Center

STEPHEN SCHENDEL, MD

  • Professor of Surgery Emeritus at Stanford University Medical Center
  • Director of the California Craniofacial Institute

GARY PERLMUTTER, MD

  • Orthopedic Shoulder Surgeon, Massachusetts General Hospital
  • Clinical Instructor, Orthopedic Surgery, Harvard Medical School

PRODUCTS


OsteoCrete® Technology

OsteoCrete® is the only FDA 510(k) cleared mixture with magnesium oxide biomaterial that is injectable, moldable, and biocompatible Bone Void Filler. Our patented proprietary process provides a unique combination of Osteoconductive and high compression strength characteristics producing the ideal Bone Void Filler for bony voids or defects that are not intrinsic to the stability of the bony structure.

Next Generation Biomaterial:

  • ✓ Excellent handling and ease-of-use
  • ✓ Can be Molded to fit uncontained bone voids
  • ✓ Radiopaque to facilitate injection
  • ✓ Will resorb into both cancellous and cortical bone
  • ✓ Will provide 3-D structure, which plays a key Osteoconductive role in bone regeneration
  • ✓ Biocompatibility and safety
  • ✓ Available in 5, 10 and 15cc Kits

Why Magnesium?
Facts about magnesium:

  • Contributes to the structural development of bone
  • Approximately 60% of magnesium in the body resides in the bone
  • Magnesium deficiency can contribute to osteoporosis
  • Plays a role in the active transport of calcium and potassium ions across cell membranes

10141 REV.E.

Resources

RESEARCH PAPERS

*All studies summaries are available upon request through customer service.

SYMBOLS GLOSSARY


BSI-SYMBOLS

Careers

Currently, there are no Openings available.

Company Policy/Procedural Compliance
Follow all company policies and procedures as well as local, state and federal laws concerning employment to include, but not limited to: I-9 information, EEOC, Civil Rights and ADA.

DISTRIBUTORSHIPS

BSI is actively seeking highly motivated distributors. We value our distributors and view distributors as strategic partners.

For more information on becoming a distributor please contact us today.

Company Policy/Procedural Compliance
Follow all company policies and procedures as well as local, state and federal laws concerning employment to include, but not limited to: I-9 information, EEOC, Civil Rights and ADA.

News


01/23/2018
BONE SOLUTIONS INC. REACHES 50 IMPLANTS OF ITS PROPRIETARY MAGNESIUM-BASED BONE VOID FILLER

09/19/2017
Bone Solutions Inc. Launches OsteoCrete®
Magnesium-Based Bone Void Filler

03/04/2014
Drew Diaz named President of Bone Solutions Inc. (BSI)

06/22/2009
Bone Solutions Inc.: Recipient of the North American Bone Graft Technology Leadership of the Year Award.

06/08/2009
Bone Solutions Inc. (BSI) receives FDA 510(K) clearance for OsteoCrete®, a magnesium-based bone void filler.

Contact us

BONE SOLUTIONS INC.

5712 COLLEYVILLE BLVD., SUITE 210
COLLEYVILLE, TEXAS 76034

Phone: 817.809.8850
Email: customerservice@bonesolutions.net

©2017 Bone Solutions, Inc. All Rights Reserved.